EGR2 and B-cell chronic lymphocytic leukemia: Additionally, EGR2, a transcription factor activated by ERK phosphorylation during BcR signaling, has been found mutated in 2-4% of CLL patients and up to 7-8% in those with advanced-stage disease or Richter transformation (34, 36, 54).